| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Joachim Fandrey | Q59550768 |
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| P433 | issue | 6 | |
| P921 | main subject | erythropoietin | Q218706 |
| P304 | page(s) | R977-88 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression | |
| P478 | volume | 286 |
| Q44492451 | A mouse model of adult-onset anaemia due to erythropoietin deficiency. |
| Q35930789 | A pharmacological investigation of Hippophae salicifolia (HS) and Hippophae rhamnoides turkestanica (HRT) against multiple stress (C-H-R): an experimental study using rat model |
| Q36482354 | AMP-activated protein kinase and the regulation of Ca2+ signalling in O2-sensing cells |
| Q89860378 | Acai Extract Transiently Upregulates Erythropoietin by Inducing a Renal Hypoxic Condition in Mice |
| Q38548790 | Adaptation of iron requirement to hypoxic conditions at high altitude |
| Q46935853 | Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight. |
| Q49375977 | Alternative Erythropoietin Receptors in the Nervous System |
| Q36504354 | Biochemistry, physiology, and complications of blood doping: facts and speculation |
| Q37456976 | Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives |
| Q98165028 | CITED2 and the modulation of the hypoxic response in cancer |
| Q41398632 | Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat. |
| Q37258724 | Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia |
| Q39499141 | Characterization of a hypoxia-response element in the Epo locus of the pufferfish, Takifugu rubripes |
| Q48715044 | Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain |
| Q46164719 | Chronic hypoxia decreases endothelial nitric oxide synthase protein expression in fetal guinea pig hearts |
| Q36283435 | Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia |
| Q36999068 | Control of erythropoietin gene expression and its use in medicine |
| Q33454496 | Counterpoint: Hypobaric hypoxia does not induce different responses from normobaric hypoxia |
| Q36651392 | DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. |
| Q42003728 | EV-3, an endogenous human erythropoietin isoform with distinct functional relevance |
| Q90633136 | Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin |
| Q48421723 | Effect of hypoxia on circulating levels of retina-specific messenger RNA in type 2 diabetes mellitus |
| Q42474198 | Effect of sustained hypobaric hypoxia during maturation and aging on rat myocardium. I. Mechanical activity |
| Q50238150 | Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients |
| Q39902159 | Epidermal sensing of oxygen is essential for systemic hypoxic response |
| Q33829114 | Erythrocytosis associated with a novel missense mutation in the HIF2A gene |
| Q35673075 | Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways |
| Q50437605 | Erythropoiesis: Physiology, pathophysiology, and algorithm for classification of the type of anemia |
| Q86260187 | Erythropoietin |
| Q37115501 | Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India |
| Q34606348 | Erythropoietin after a century of research: younger than ever |
| Q84989610 | Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia |
| Q50616816 | Erythropoietin and the skin: a role for epidermal oxygen sensing? |
| Q40105182 | Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia |
| Q37496924 | Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. |
| Q48139522 | Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice |
| Q34768481 | Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. |
| Q37862940 | Erythropoietin: a hormone with multiple functions |
| Q42922791 | Erythropoietin: a multimodal neuroprotective agent |
| Q26999392 | Erythropoietin: powerful protection of ischemic and post-ischemic brain |
| Q49758040 | Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models |
| Q30480096 | Functional conservation of erythropoietin signaling in zebrafish |
| Q54651719 | HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart. |
| Q33404963 | HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis |
| Q34282364 | Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. |
| Q35578595 | Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in mice |
| Q64086693 | Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair |
| Q24629323 | Hypoxia-Inducible Factors and the Response to Hypoxic Stress |
| Q28594830 | Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo |
| Q28303287 | Hypoxia-inducible factors in the kidney |
| Q37849079 | Hypoxia. 5. Hypoxia and hematopoiesis |
| Q46323076 | Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization |
| Q24609166 | Hypoxic regulation of erythropoiesis and iron metabolism |
| Q40825620 | Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice |
| Q34362232 | Intrauterine ischemic reperfusion switches the fetal transcriptional pattern from HIF-1α- to P53-dependent regulation in the murine brain |
| Q37848245 | Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim |
| Q36600985 | Mechanisms of disease: erythropoietin--an old hormone with a new mission? |
| Q37612046 | Mechanisms of intermittent hypoxia induced hypertension |
| Q34505760 | Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects |
| Q33758734 | Nanoscopy of the cellular response to hypoxia by means of fluorescence resonance energy transfer (FRET) and new FRET software |
| Q40351941 | Nanostructure of specific chromatin regions and nuclear complexes. |
| Q37323984 | Natriuretic peptides in hormonal regulation of hypoxia responses. |
| Q33382906 | New insights into the mechanisms of nonimmune thrombocytopenia in neonates |
| Q44937187 | Nitric oxide modulates hypoxia-inducible factor-1 and poly(ADP-ribose) polymerase-1 cross talk in response to hypobaric hypoxia. |
| Q37375988 | Nonrenal regulation of EPO synthesis |
| Q38876587 | Optical Analysis of Hypoxia Inducible Factor (HIF)-1 Complex Assembly: Imaging of Cellular Oxygen Sensing |
| Q35305543 | Organ specific regenerative markers in peri-organ adipose: kidney |
| Q26827518 | Oxygen sensing in retinal health and disease |
| Q39575637 | Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC. |
| Q50895779 | Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma. |
| Q50234877 | Physiological focus on the erythropoietin-hepcidin-ferroportin axis |
| Q94487083 | Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions |
| Q37738315 | Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway |
| Q33418304 | Regulation of clock-controlled genes in mammals |
| Q42271017 | Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements |
| Q38123955 | Renal anemia: from incurable to curable |
| Q64111741 | Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial |
| Q37070683 | Stem cells for the treatment of skeletal muscle injury |
| Q35576516 | Suppression of erythropoiesis by dietary nitrate. |
| Q50673297 | Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). |
| Q39101277 | Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients |
| Q55078229 | The Janus Face of VEGF in Stroke. |
| Q36866696 | The Local HIF-2α/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness |
| Q42170481 | The anemia of the newborn induces erythropoietin expression in the developing mouse retina |
| Q34961434 | The causes of porotic hyperostosis and cribra orbitalia: a reappraisal of the iron-deficiency-anemia hypothesis |
| Q37639378 | The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery |
| Q37403106 | The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. |
| Q37995093 | The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use. |
| Q35038220 | The oxygen sensing signal cascade under the influence of reactive oxygen species |
| Q41573021 | The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits |
| Q37195742 | The role of erythropoietin as an inhibitor of tissue ischemia |
| Q48421828 | The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. |
| Q36947417 | Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond |
| Q36102876 | Two new mutations in the HIF2A gene associated with erythrocytosis. |
| Q61866159 | Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS) |
| Q26765294 | Vascular endothelial growth factor: an attractive target in the treatment of hypoxic/ischemic brain injury |
| Q38120064 | What is hypoxia? |
| Q24304157 | Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene |
Search more.